How Latent Labs Plans To Create Medicines From Scratch With AI
Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...
Pharm Exec2d
Latent Labs Launches Publicly with $50 Million in Funding for Artificial Intelligence-Powered Programmable Biology
As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...
ProPhase Labs appoints new COO amid executive changes
ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...
Latent Labs raises $50M to develop new proteins with AI
Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...
Alkem Labs, Ipca, Divi's: Three reasons why pharma stocks are falling today
Stocks such as Natco, Dr. Reddy's, Cipla, Mankind, Torrent, Sun Pharma, Abbott, and Glenmark slipped in the range of 1-2 per ...
Pharma stocks decline as Nifty Pharma index slips 2%; Alkem, Ipca, Divi’s lead losses
Pharma stocks tumbled as the Nifty Pharma index dropped two percent, with Alkem, Ipca, and Divi’s Labs leading losses.